Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel

Maria C B de Leon, Sridhar Bolla, Barbra Greene, Lauren Hutchinson, Giuseppe Del Priore

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

•First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel•We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.

Original languageEnglish
Pages (from-to)70-71
Number of pages2
JournalGynecologic Oncology Case Reports
Volume5
DOIs
StatePublished - Aug 2013

Fingerprint

docetaxel
Paclitaxel
Hypersensitivity
Drug Therapy
Therapeutics
130-nm albumin-bound paclitaxel

Keywords

  • Abraxane
  • Docetaxel
  • Hypersensitivity reaction
  • Nab-paclitaxel
  • Paclitaxel
  • Taxol

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel. / de Leon, Maria C B; Bolla, Sridhar; Greene, Barbra; Hutchinson, Lauren; Del Priore, Giuseppe.

In: Gynecologic Oncology Case Reports, Vol. 5, 08.2013, p. 70-71.

Research output: Contribution to journalArticle

de Leon, Maria C B ; Bolla, Sridhar ; Greene, Barbra ; Hutchinson, Lauren ; Del Priore, Giuseppe. / Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel. In: Gynecologic Oncology Case Reports. 2013 ; Vol. 5. pp. 70-71.
@article{441b7750e3534417bb8220bb5b953d3a,
title = "Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel",
abstract = "•First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel•We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.",
keywords = "Abraxane, Docetaxel, Hypersensitivity reaction, Nab-paclitaxel, Paclitaxel, Taxol",
author = "{de Leon}, {Maria C B} and Sridhar Bolla and Barbra Greene and Lauren Hutchinson and {Del Priore}, Giuseppe",
year = "2013",
month = "8",
doi = "10.1016/j.gynor.2013.05.003",
language = "English",
volume = "5",
pages = "70--71",
journal = "Gynecologic Oncology Reports",
issn = "2211-338X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel

AU - de Leon, Maria C B

AU - Bolla, Sridhar

AU - Greene, Barbra

AU - Hutchinson, Lauren

AU - Del Priore, Giuseppe

PY - 2013/8

Y1 - 2013/8

N2 - •First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel•We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.

AB - •First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel•We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.

KW - Abraxane

KW - Docetaxel

KW - Hypersensitivity reaction

KW - Nab-paclitaxel

KW - Paclitaxel

KW - Taxol

UR - http://www.scopus.com/inward/record.url?scp=84879306090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879306090&partnerID=8YFLogxK

U2 - 10.1016/j.gynor.2013.05.003

DO - 10.1016/j.gynor.2013.05.003

M3 - Article

AN - SCOPUS:84879306090

VL - 5

SP - 70

EP - 71

JO - Gynecologic Oncology Reports

JF - Gynecologic Oncology Reports

SN - 2211-338X

ER -